Outcomes of Acinetobacter baumannii infection in critically ill surgical patients

Surgical Infections

Volumn 8, Issue 4, 2007, Pages 437-443

  Trottier, Vincent ^a   Namias, Nicholas ^a   Pust, Daniel G ^a   Nuwayhid, Zaher ^a   Manning, Ronald ^a   Marttos Jr , Antonio C ^a   Dunham, Michael B ^a   Schulman, Carl I ^a   Mckenney, Mark G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CILASTATIN PLUS IMIPENEM; COLISTIN;

ABSCESS; ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIUM CULTURE; CATHETER; CONFERENCE PAPER; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; SURGICAL WOUND; TRANSPLANTATION; URINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COLISTIN; CRITICAL ILLNESS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FLORIDA; HOSPITAL MORTALITY; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES;

EID: 34848875742     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.029     Document Type: Conference Paper

References (28)

1. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee. JAMA 1995;274:639-644.
2. Dickama DJ and the SENTY Participants Group. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. Int J Antimicrob Agents 2000;13:257-271.
3. Paul M, Weinberger M, Siegman-Igra Y, et al. Acinetobacter baumannii: Emergence and spread in Israeli hospitals 1997-2002. J Hosp Infect 2005;60:256-260.
4. Minnangati VR, Cunha BA. Acinetobacter baumannii- associated arterial line infection. Am J Infect Control 2000;28:376-377.
5. Hanberger J and the French and Portuguese ICU Study Group. Antibiotic susceptibility among aerobic gram-negative bacilli in ICU in 5 European countries. JAMA 1999;28:67-70.
6. Husni RN, Goldstein LS, Arroliga AC, et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115:1378-1382.
7. Aktas O, Ozbek A. Prevalence and in-vitro antimicrobial susceptibility patterns of Acinetobacter strains isolated from patients in intensive care units. J Int Med Res 2003;31:272-280.
8. Das I, Lambert P, Hill D, et al. Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect 2002;50:110-114.
9. Herruzo R, Cruz J de la, Fernandez-Acenero MJ, et al. Two consecutive outbreaks of Acinetobacter baumannii 1-a in a burn intensive care unit for adults. Burns 2004;30:419-423.
10. Koprnova J, Babela R, Svetlansky I, et al. Acinetobacter baumannii bacteremia in surgical patients [letter]. Eur J Surg 2001;167:556-557.
11. Sherertz RJ, Sullivan ML. An outbreak of infections Acinetobacter calcoaceticus in burn patients: Contamination of patients' mattresses. J Infect Dis 1985;151: 252-258.
12. Weernink A, Severin WPJ, Tjernberg I, et al. Pillows, an unexpected source of Acinetobacter. J Hosp Infect 1995;29:189-199.
13. Hartstein AI, Rashad AL, Liebler JM, et al. Multiple intensive care unit outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infection and colonization associated with contaminated reusable ventilator circuits and resuscitation bags. Am J Med 1998;85:624-631.
14. Koprnova J, Babela R, Svetlansky I, et al. Prospective study of antibacterial susceptibility, risk factors and outcome of 157 episodes of Acinetobacter baumannii bacteremia in 1999 in Slovakia. Scand J Infect Dis 2001;33:891-895.
15. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez J et al. Treatment of multidrug resistant Acinetobacter baumannii ventilator associated pneumonia (VAP) with intravenous Colistin: A comparison with imipenem-susceptible VAP. Clin Infect Dis 2003;36:1111-1118.
16. Levin AS, Barone AA, Penco J, et al. Intravenous Colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999;28:1008-1011.
17. Michalopoulos A, Kasiakou SK, Mastora Z, et al. Aerosolized Colistin for the treatment of nosocomial pneumonia due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005;9:R53-R59.
18. Kwa ALH, Low CS, Low JGH, et al. Nebulized Colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2005;41:754-757.
19. Berlana D, Llop JM, Fort E, et al. Use of Colistin in the treatment of multiple-drug-resistant gram-negative infections. Am J Health-Syst Pharm 2005; 62:39-47.
20. Michalopoulos AS, Tsiodras S, Rellos K, et al. Colistin treatment in patients with ICU-acquired infections caused by multiresistant gram-negative bacteria: The renaissance of an old antibiotic. Clin Microbiol Infect 2005;11:115-121.
21. Reina R, Estenssoro E, Saenz G, et al. Safety and efficacy of Colistin in Acinetobacter and Pseudomonas infections: A prospective cohort study. Intensive Care Med 2005;31:1058-1065.
22. Montero A, Ariza J, Corbella X, et al. Efficacy of Colistin versus β-lactams, aminoglycosides and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob Agents Chemother 2002;46:1946-1952.
23. Markou N, Apostolakos H, Koumoudiou C, et al. Intravenous Colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients. Crit Care 2003;7:R78-R83.
24. Bradford PA, Weaver-Sands T, Petersen PJ. In vitro activity of tigecycline against isolates from patients enrolled in Phase 3 clinical trials of treatment for complicated skin and skin-structures infections and complicated intra-abdominal infections. Clin Infect Dis 2005;41:S315-S332.
25. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: A matched cohort study. Intensive Care Med 2003;29:471-475.
26. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, et al. Acinetobacter baumannii ventilator associated pneumonia: Epidemiological and clinical findings. Intensive Care Med 2005;31:649-655.
27. Manfredi R, Nanetti A, Valentini R et al. Acinetobacter infections in patients with human immunodeficiency virus infection: Microbiological and clinical epidemiology. Chemotherapy 2001;47:19-28.
28. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: A cohort study. Clin Infect Dis 2001;33:939-946.